JOUNCE THERAPEUTICS INC (JNCE) 1.21 0 (0%)
1.21 0 (0%)
US4811161011 - Common Stock - After market: 1.21 0 (0%)
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 26.91M | 62.30M | 147.90M | 65.20M | |||
| Operating Expenses | 132.86M | 117.96M | 107.50M | 95.10M | 96.50M | |||
| Income Before Taxes | -132.09M | -90.86M | -43.80M | 56.90M | -27.30M | |||
| Income Tax | 24.00K | 15.00K | 0.00 | 0.00 | 0.00 | |||
| Net Income | -132.11M | -90.87M | -43.80M | 56.80M | -27.40M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.56 | -1.82 | -1.24 | 1.66 | -0.84 | |||
| Non GAAP EPS | -2.56 | -1.84 | -1.47 | 1.63 | -0.83 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -337.73% | -70.30% | 38.40% | -42.02% | |||
All data in USD